Zhi Shi
Ministry of Education of the People's Republic of China(CN)Jinan University(CN)University of Washington(US)Key Laboratory of Guangdong Province(CN)Nutrition Sciences (Belgium)(BE)Guangdong Provincial People's Hospital(CN)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Cancer therapeutics and mechanisms, RNA Interference and Gene Delivery, MicroRNA in disease regulation, HIV/AIDS drug development and treatment
Most-Cited Works
- → Erlotinib (Tarceva, OSI-774) Antagonizes ATP-Binding Cassette Subfamily B Member 1 and ATP-Binding Cassette Subfamily G Member 2–Mediated Drug Resistance(2007)326 cited
- → pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities(2017)194 cited
- → Sildenafil Reverses ABCB1- and ABCG2-Mediated Chemotherapeutic Drug Resistance(2011)168 cited
- → Human Multidrug Resistance Protein 7 ( ABCC10 ) Is a Resistance Factor for Nucleoside Analogues and Epothilone B(2008)153 cited
- → Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo(2006)140 cited
- → Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer(2019)132 cited